Today: 12 April 2026
Sasol share price jumps as oil spike shakes markets — what JSE investors watch next
2 March 2026
1 min read

Sasol share price jumps as oil spike shakes markets — what JSE investors watch next

Johannesburg, March 2, 2026, 16:04 (SAST) — Regular session on the tape.

Sasol Ltd (JSE: SOL) advanced 5.6% Monday, the stock drawing attention as crude prices surged amid the Iran conflict. Shares hit a 52-week peak at 163.55 rand before settling at 153.44 rand by 3:36 pm, dipping as low as 151.23 rand at one point, according to Sharenet. That comes on the heels of Friday’s sharp 16% rally.

Sasol trades in Johannesburg and often stands in as South Africa’s oil proxy—so when energy prices swing, the shares usually don’t sit still for long.

That’s taking on greater urgency as crude markets adjust to supply risk, with traders weighing how pricier oil could impact margins and demand in the coming weeks.

Sasol posted a 34% fall in half-year headline earnings per share last week, with the figure excluding certain one-off items under South African accounting. The company once again held back on its dividend; net debt remained north of $3 billion, a level that keeps the payout policy on pause, according to a Reuters report.

Brent crude surged up to 13%, touching $82.37 a barrel—levels not seen since January 2025—before settling nearer $78.92 by 1215 GMT, according to Reuters. “The latest move reflects uncertainty around the scale and duration of the current conflict,” said James Hosie at Shore Capital. Citi analysts are looking for Brent to stay in the $80 to $90 range this week. JP Morgan, meanwhile, flagged that any extended disruption at the Strait of Hormuz could send prices above $100. Reuters

The rand slipped further, complicating local price action. Early session trading saw it at 16.16 to the dollar—down roughly 1.4% since Friday’s close, according to Reuters. ETM Analytics noted that after the weekend’s events, investors kept flocking to the dollar for safety amid the latest round of volatility.

A company-specific drag lingered in the mix. Industrial group KAP announced an arbitrator sided with its interpretation of ethylene pricing in a dispute involving its Safripol arm and Sasol, handing costs to Safripol. Sasol can still take the issue to the High Court for review. KAP added that a separate quarrel over supply volumes isn’t settled yet.

Sasol investors face a legal process that’s sluggish and tangled—a sideshow for now. What actually moves the shares is crude: oil price swings can lift the stock, but those gains are just as quick to vanish when the news cycle flips.

The rally could face pressure if oil retreats or if higher energy costs drag harder on global growth. A court review over the ethylene award—or a negative ruling from competition authorities—means more expense and headaches, especially with debt levels still under scrutiny.

Energy markets are eyeing April 5, the date when eight OPEC+ nations set to ramp up supply will reconvene to assess the state of play. Sasol traders are gauging whether oil prices can hold up through then.

Stock Market Today

  • Is CRISPR Therapeutics (CRSP) Overvalued Following Recent Share Price Recovery?
    April 12, 2026, 3:37 AM EDT. CRISPR Therapeutics (CRSP) shares have risen 3.5% over the past week and 5.1% over the past month, with a 30.3% gain over the last year, despite a 4.7% decline year-to-date and a 56.8% drop over five years. The gene-editing firm currently trades around $51.22, while a Discounted Cash Flow (DCF) analysis estimates an intrinsic value near $189.38, implying the stock is about 73% undervalued. The DCF model forecasts the company's free cash flow turning positive by 2030, reaching $204.5 million, up from a recent $345.4 million loss. CRISPR's valuation score stands at 3 out of 6, reflecting mixed signals amid optimism over its gene-editing platform and partnerships. Investors are weighing the balance of future growth potential against current financial risks in determining if the stock price reflects too much hope or opportunity.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 11:59 PM EDT DocuSign Stock Review: Is the 42% Yearly Drop a Buying Opportunity? April 11, 2026, 11:59 PM EDT. DocuSign (DOCU) shares have fallen 42.3% over the past year, raising questions about their value. Despite recent weakness, a Discounted Cash Flow (DCF) analysis suggests the stock is 68.1% undervalued, with estimated intrinsic value around $134.42 versus a current price near $42.89. The DCF model projects growing free cash flows from $990 million in 2026 to $1.37 billion by 2029. Investors remain cautious amid evolving software spending trends
Accelerant stock slips in premarket after 10% pop; ARX traders eye March 19 earnings test
Previous Story

Accelerant stock slips in premarket after 10% pop; ARX traders eye March 19 earnings test

Crescent Energy stock jumps in premarket as oil spikes; CRGY nears 52-week high
Next Story

Crescent Energy stock jumps in premarket as oil spikes; CRGY nears 52-week high

Go toTop